Trends in postacute myocardial infarction management and mortality in patients with diabetes. A population-based study from 1995 to 2001

Canadian Journal of Cardiology

Volumn 26, Issue 10, 2010, Pages 523-531

  Ouhoummane, Najwa ^a   Abdous, Belkacem ^b   Louchini, Rabia ^a   Rochette, Louis ^a   Poirier, Paul ^c  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Acute myocardial infarction; Diabetes mellitus; Mortality; Revascularization

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DATA BASE; DIABETES MELLITUS; FATALITY; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; PROGNOSIS; RETROSPECTIVE STUDY; TREND STUDY;

EID: 78650187535     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(10)70465-7     Document Type: Article

References (51)

1. Public Health Agency of Canada. Responding to the Challenge of Diabetes in Canada. First Report of the National Diabetes Surveillance System (NDSS) 2003. Ottawa: Public Health Agency of Canada, 2003.
2. Katzmarzyk PT, Mason C. Prevalence of class I, II and III obesity in Canada. CMAJ 2006;174:156-7.
3. Gauthier H, Jean S, Langis G, Nobert Y, Rochon M. [The Life Course of Birth Cohorts and the Elderly: Today and Tomorrow] - Volume 1. Quebec: Institut de la Statistique du Québec, 2004.
4. Alter DA, Khaykin Y, Austin PC, Tu JV, Hux JE. Processes and outcomes of care for diabetic acute myocardial infarction patients in Ontario: Do physicians undertreat? Diabetes Care 2003;26:1427-34.
5. Masoudi FA, Foody JM, Havranek EP, et al. Trends in acute myocardial infarction in 4 US states between 1992 and 2001: Clinical characteristics, quality of care, and outcomes. Circulation 2006;114:2806-14.
6. Pilote L, Lavoie F, Ho V, Eisenberg MJ. Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995. CMAJ 2000;163:31-6.
7. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7.
8. Tu JV, Naylor CD, Austin P. Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. CMAJ 1999;161:1257-61.
9. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98.
10. Mosterd A, D'Agostino RB, Silbershatz H, et al. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med 1999;340:1221-7.
11. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999;281:1291-7.
12. Thomas RJ, Palumbo PJ, Melton LJ, et al. Trends in the mortality burden associated with diabetes mellitus: A population-based study in Rochester, Minn, 1970-1994. Arch Intern Med 2003;163:445-51.
13. Norhammar A, Malmberg K, Ryden L, Tornvall P, Stenestrand U, Wallentin L. Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003;24:838-44.
14. Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial. Lancet 2004;364:685-96.
15. Booth GL, Kapral MK, Fung K, Tu JV. Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 2006;29:32-7.
16. Kamalesh M, Subramanian U, Ariana A, Sawada S, Tierney W. Similar decline in post-myocardial infarction mortality among subjects with and without diabetes. Am J Med Sci 2005;329:228-33.
17. Norhammar A, Lindback J, Ryden L, Wallentin L, Stenestrand U. Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: A time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart 2007;93:1577-83.
18. Svensson AM, Dellborg M, Abrahamsson P, et al. The influence of a history of diabetes on treatment and outcome in acute myocardial infarction, during two time periods and in two different countries. Int J Cardiol 2007;119:319-25.
19. Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes: Part II: Recent advances in coronary revascularization. J Am Coll Cardiol 2007;49:643-56.
20. Smith SC Jr, Faxon D, Cascio W, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: Revascularization in diabetic patients. Circulation 2002;105:e165-9.
21. Soares PR, Hueb WA, Lemos PA, et al. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: An analysis from the Medicine, Angioplasty, or Surgery Study (MASS II). Circulation 2006;114:I420-4.
22. Levy AR, Tamblyn RM, Fitchett D, McLeod PJ, Hanley JA. Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction. Can J Cardiol 1999;15:1277-82.
23. Pilote L, Merrett P, Karp I, et al. Cardiac procedures after an acute myocardial infarction across nine Canadian provinces. Can J Cardiol 2004;20:491-500.
24. Udvarhelyi IS, Gatsonis C, Epstein AM, Pashos CL, Newhouse JP, McNeil BJ. Acute myocardial infarction in the Medicare population. Process of care and clinical outcomes. JAMA 1992;268:2530-6.
25. Blanchard JF, Ludwig S, Wajda A, et al. Incidence and prevalence of diabetes in Manitoba, 1986-1991. Diabetes Care 1996;19:807-11.
26. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: A population-based study. Lancet 2007;369:750-6.
27. Simpson SH, Corabian P, Jacobs P, Johnson JA. The cost of major comorbidity in people with diabetes mellitus. CMAJ 2003;168:1661-7.
28. Alter DA, Tu JV, Austin PC, Naylor CD. Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada. J Am Coll Cardiol 2003;42:410-9.
29. Petersen MR, Deddens JA. Re: "Easy SAS calculations for risk or prevalence ratios and differences". Am J Epidemiol 2006;163:1158-9.
30. Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007;297:1892-900.
31. Vaccarino V, Rathore SS, Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 2005;353:671-82.
32. Booth GL, Rothwell DM, Fung K, Tu JV. Diabetes and cardiac disease. In: Hux JE, Booth GL, Slaughter PM, Laupacis A, eds. Diabetes in Ontario: An ICES Practice Atlas. Toronto: Institute for Clinical Evaluative Sciences, 2003.
33. Waldecker B, Waas W, Haberbosch W, et al. Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients. Diabetes Care 1999;22:1832-8.
34. Frye RL, August P, Brooks MM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503-15.
35. Bravata DM, Gienger AL, McDonald KM, et al. Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007;147:703-16.
36. Van Domburg RT, Foley DP, Breeman A, van Herwerden LA, Serruys PW. Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. Twenty-year clinical outcome. Eur Heart J 2002;23:543-9.
37. Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005;46:575-81.
38. Rozenman Y, Sapoznikov D, Mosseri M, et al. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: A clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation. J Am Coll Cardiol 1997;30:1420-5.
39. Abizaid A, Costa MA, Centemero M, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: Insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 2001;104:533-8.
40. Legrand VM, Serruys PW, Unger F, et al. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation 2004;109:1114-20.
41. Bair TL, Muhlestein JB, May HT, et al. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: Results from the Intermountain Heart Registry. Circulation 2007;116:I226-31.
42. Srinivas VS, Brooks MM, Detre KM, et al. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: A comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study. Circulation 2002;106:1627-33.
43. Schnell O, Schafer O, Kleybrink S, Doering W, Standl E, Otter W. Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: The Munich registry. Diabetes Care 2004;27:455-60.
44. Cubbon RM, Wheatcroft SB, Grant PJ, et al. Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: A comparison of over 3000 patients between 1995 and 2003. Eur Heart J 2007;28:540-5.
45. Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with statins in high-risk elderly patients: The treatment-risk paradox. JAMA 2004;291:1864-70.
46. Stukel TA, Lucas FL, Wennberg DE. Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare Patients with acute myocardial infarction. JAMA 2005;293:1329-37.
47. Imperatore G, Cadwell BL, Geiss L, et al. Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. Am J Epidemiol 2004;160:531-9.
48. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 2006;144:465-74.
49. Sirois C, Moisan J, Poirier P, Gregoire JP. Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes. Diabetes Care 2007;30:1880-2.
50. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
51. Goldberg RJ, Glatfelter K, Burbank-Schmidt E, Farmer C, Spencer FA, Meyer T. Trends in mortality attributed to heart failure in Worcester, Massachusetts, 1992 to 2001. Am J Cardiol 2005;95:1324-8.